Basic Information | Post buying leads | Suppliers | Cas Database |
The 4-Biphenylacetic acid ethyl ester with the cas number 14062-23-8 is also called [1,1'-Biphenyl]-4-aceticacid, ethyl ester. The IUPAC name is ethyl 2-(4-phenylphenyl)acetate. Its molecular formula is C16H16O2. The product's category is Biphenyl & Diphenyl ether.
The properties of the chemical are: (1)ACD/LogP: 4.26; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 4.25; (4)ACD/LogD (pH 7.4): 4.25; (5)ACD/BCF (pH 5.5): 1008.27; (6)ACD/BCF (pH 7.4): 1008.27; (7)ACD/KOC (pH 5.5): 4915.42; (8)ACD/KOC (pH 7.4): 4915.42; (9)#H bond acceptors: 2; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 26.3 Å2; (13)Index of Refraction: 1.55; (14)Molar Refractivity: 71.43 cm3; (15)Molar Volume: 224 cm3; (16)Polarizability: 28.31×10-24cm3; (17)Surface Tension: 39.4 dyne/cm; (18)Enthalpy of Vaporization: 60.26 kJ/mol; (19)Vapour Pressure: 2.77×10-5 mmHg at 25°C.
Uses: This chemical can prepare 2-biphenyl-4-yl-acetic acid hydrazide. This reaction needs reagent NH2NH2*H2O and solvent ethanol at temperature of 100 °C. The reaction time is 3.0 hours. The yield is 79%.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(OCC)Cc1ccc(cc1)c2ccccc2
(2)InChI: InChI=1/C16H16O2/c1-2-18-16(17)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,2,12H2,1H3
(3)InChIKey: NPPJLSILDPVHCM-UHFFFAOYAL
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 250mg/kg (250mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |
mouse | LD50 | intravenous | 337mg/kg (337mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |
mouse | LD50 | oral | 652mg/kg (652mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |
mouse | LD50 | subcutaneous | 646mg/kg (646mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |
rat | LD50 | intravenous | 288mg/kg (288mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |
rat | LD50 | oral | 385mg/kg (385mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |
rat | LD50 | subcutaneous | 321mg/kg (321mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: OTHER CHANGES | Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 15, Pg. 3437, 1987. |